Provided by Tiger Trade Technology Pte. Ltd.

Nasus Pharma Ltd.

4.00
+0.15003.90%
Post-market: 4.000.00000.00%16:10 EDT
Volume:29.90K
Turnover:116.19K
Market Cap:47.04M
PE:-3.74
High:4.00
Open:3.81
Low:3.66
Close:3.85
52wk High:9.99
52wk Low:1.98
Shares:11.76M
Float Shares:6.21M
Volume Ratio:1.49
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0691
EPS(LYR):-0.7311
ROE:-316.04%
ROA:-96.73%
PB:4.28
PE(LYR):-5.47

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 27, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 25, 2026

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 11, 2026

Correspondence

Form CORRESP - Correspondence
Mar 02, 2026

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Aug 09, 2025

Correspondence

Form CORRESP - Correspondence
Aug 09, 2025

Correspondence

Form CORRESP - Correspondence
Aug 08, 2025

Correspondence

Form CORRESP - Correspondence
Aug 07, 2025

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Jul 30, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 28, 2025

Correspondence

Form CORRESP - Correspondence
Jul 28, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 28, 2025

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Jul 09, 2025

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers